In 1960, Mather [I] stated that "bilirubin determinations are perhaps the most notoriously unreliable of any in clinical chemistry."
Twenty-two years later, Watkinson et al. [2] came to much the same conclusion. Now, the study by Vreman et al. [3] reveals that accuracy in measuring serum total bilirubin can be elusive even in university hospitals. It is, indeed, disturbing to see bilirubin results seemingly so unreliable that for one specimen the reported concentrations ranged from 110 to 210 mg/L (188 to 359 .tmol/L) when all of the laboratories' results are included. In this editorial, we will attempt to identify potential sources of real and apparent inaccuracy and imprecision in with an SD of 550 [5] . Because the SD is very small, we propose that a range of 75500 ± 1900 (±2.5% of the mean value) be used as a criterion of accuracy of bilirubin calibrators. Additional criteria for accuracy should be the #{128} values of bilirubin in caffeine reagent at 432 and 457 nm; the reported #{128}432nm and #{128}457nm mean values and ranges are 49 500 (± 1300) and 48 800 (± 1300) Lmolcm1, respectively [6] . The data from the Ektachem, the most commonly used instrument in the study, are particularly puzzling to us. Two of the Ektachems (#2 and 4) gave consistently low results, three (#5, 6, and 7) were reasonably near Sigma's assigned values, and four (#9, 10, 11, 14) were consistently high. In addition, several of the Ektachem's results (#10, 13, 14) seemed unexpectedly variable within a given laboratory through the 8 months of the study. Again, inadequate attention to instrument calibration and failure to check instrument performance across reagent (slide) lots are possible explanations.
Long-term (1 year, including several slide lot changes and recalibrations)
CVs from Ektachem analyzers in our own laboratories were -8-10% at a bilirubin concentration of 11 mg/L, and 2-3% at 180 mg/L. We believe that our intralaboratory CV of 2-3% is more consistent with the interlaboratory CVs in the College of American Pathologists (CAP) surveys (see below) than with those obtained by some of the Ektachem analyzers in the Vreman study. e.g., addition of stabilizers and preservatives, dialysis, and freeze-drying, to name but a few. In some analytical systems these materials, used for calibration or for monitoring precision and accuracy, do not behave like fresh patients' samples. That is, an analytical system that provides accurate results in patients' samples may fail to provide accurate results in processed biological materials [7, 8] .
Some methods for measuring bilirubin are very sensitive to matrix effects. For example, with diazo methods in which methanol is used as the accelerator, the "reactivity" of bilirubin varies with the protein matrix; it is highest in human serum, followed by BSA and HSA [9] . The same is true for the reactivity of ditaurobilirubin (the bilirubin conjugate often used for calibrating methods for direct bilirubin) in some diazo methods for direct bilirubin [10] . Direct spectrophotometric methods are also affected by the protein matrix. Calibrators made in matrices other than human serum may not be suitable for calibrating direct spectrophotometric methods because the absorption maximum and the #{128} value of unconjugated bilirubin vary with the protein matrix and with the process used to prepare the protein.
For example, #{128} values of unconjugated bilirubin in crystalline HSA or BSA are much higher than in the corresponding Cohn Fractions V or in human serum [11, 12] . Surface-active agents (e.g., Brij35) and the albumin fatty acid content increase the absorptivity of unconjugated bilirubin and shift its absorption maximum to longer wavelengths [11, 13] . These effects on the absorption spectra and #{128} of unconjugated bilirubin are completely abolished by substituting caffeine reagent for phosphate buffer in the direct spectrophotometry of bilirubin [6, 14] . The situation could get more complicated by the presence of ditaurobilirubin in calibrators and control sera, the spectrum and #{128} value of which are also matrix-dependent [10] .
For these reasons, therefore, a given control or calibrator preparation may appear to yield more than one "true" value for bilirubin, such that method-dependent assigned bilirubin concentrations are necessary for artificially prepared materials that are to be analyzed in clinical laboratory instruments.
As an aside, we believe that matrix effects for total bilirubin could be nearly eliminated, at least for methods involving liquid reagents, if all methods were to use caffeine-benzoate-acetate as the promoter. Although the question of whether matrix effects are responsible for some of the observed variability of Ektachem results reported by Vreman et al. cannot be answered with certainty, the lack of consistency in the direction and magnitude of the bias tend to rule against matrix effects. The numbers of the other two analyzers that were used in Vreman's study are too small to draw any meaningful conclusions. The term "neonatal bilirubin" usually denotes bilirubin measured in the blood of neonates by direct spectrophotometry. Perhaps then the perennial goal of accurate bilirubin results in general clinical practice may finally come into our grasp.
